DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 4 of 4 entries
Filter by
Reset
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
指定難病告示番号
1
JAK2
24件:
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Signaling pathways regulating pluripotency of stem cells
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Cholinergic synapse
,
Prolactin signaling pathway
,
Adipocytokine signaling pathway
,
AGE-RAGE signaling pathway in diabetic complications
,
Growth hormone synthesis, secretion and action
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Influenza A
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Pathways in cancer
,
Chemical carcinogenesis - receptor activation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Lipid and atherosclerosis
24件:
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling path
...
D09959
D09959
Ruxolitinib
3件:
60
60
,
65
,
228
2
JAK2
24件:
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Signaling pathways regulating pluripotency of stem cells
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Cholinergic synapse
,
Prolactin signaling pathway
,
Adipocytokine signaling pathway
,
AGE-RAGE signaling pathway in diabetic complications
,
Growth hormone synthesis, secretion and action
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Influenza A
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Pathways in cancer
,
Chemical carcinogenesis - receptor activation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Lipid and atherosclerosis
24件:
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling path
...
D09970
D09970
Tofacitinib
15件:
11
11
,
40
,
44
,
46
,
49
,
50
,
51
,
53
,
65
,
84
,
96
,
97
,
107
,
271
,
300
3
JAK2
24件:
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Signaling pathways regulating pluripotency of stem cells
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Cholinergic synapse
,
Prolactin signaling pathway
,
Adipocytokine signaling pathway
,
AGE-RAGE signaling pathway in diabetic complications
,
Growth hormone synthesis, secretion and action
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Influenza A
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Pathways in cancer
,
Chemical carcinogenesis - receptor activation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Lipid and atherosclerosis
24件:
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling path
...
D10308
D10308
Baricitinib
13件:
2
2
,
41
,
46
,
49
,
50
,
51
,
53
,
93
,
107
,
162
,
265
,
269
,
325
4
JAK2
24件:
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Signaling pathways regulating pluripotency of stem cells
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Cholinergic synapse
,
Prolactin signaling pathway
,
Adipocytokine signaling pathway
,
AGE-RAGE signaling pathway in diabetic complications
,
Growth hormone synthesis, secretion and action
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Influenza A
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Pathways in cancer
,
Chemical carcinogenesis - receptor activation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Lipid and atherosclerosis
24件:
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling path
...
D10653
D10653
Peficitinib
1件:
46
46